第一作者机构：[1]Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
推荐引用方式(GB/T 7714)：
Lv Huilai,Tian Yang,Huang Chao,et al.Camrelizumab combined with albumin paclitaxel and cisplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESCC).[J].JOURNAL OF CLINICAL ONCOLOGY.2021,39(15):doi:10.1200/JCO.2021.39.15_suppl.e16021.
APA：
Lv, Huilai,Tian, Yang,Huang, Chao,Li, Zhenhua&Tian, Ziqiang.(2021).Camrelizumab combined with albumin paclitaxel and cisplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESCC)..JOURNAL OF CLINICAL ONCOLOGY,39,(15)
MLA：
Lv, Huilai,et al."Camrelizumab combined with albumin paclitaxel and cisplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESCC).".JOURNAL OF CLINICAL ONCOLOGY 39..15(2021)
医学